中文 | English
Return
Total: 17 , 1/2
Show Home Prev Next End page: GO
Author:( Fengru ZHANG)

1.Advance of growth factor-independent 1B(GFI1B) in common hematologic diseases

Zhimin ZHANG ; Fengru LIN

Journal of Leukemia & Lymphoma 2009;18(12):758-760

2.Mammalian target of rapamycin and leukemia treatment

Lihong ZHANG ; Fengru LIN

Journal of Leukemia & Lymphoma 2008;17(6):469-471

3.Clinical application and mechanism researches of acupuncture with theoy of Shugan-Tiaoshen

Fengru CHENG ; Baoyun ZHANG ; Dianhui YANG

International Journal of Traditional Chinese Medicine 2021;43(5):517-520

4.Epigenetics and targeted therapy in myelodysplastic syndrome: reports from the 56th American Society of Hematology annual meeting

Fengru LIN ; Jingyu ZHANG ; Yan WANG

Journal of Leukemia & Lymphoma 2015;24(3):129-131

5.Advances in the treatment of JAK2 V617F gene mutation positive myeloproliferative neoplasms

Fengru LIN ; Yan WANG ; Jingyu ZHANG

Journal of Leukemia & Lymphoma 2015;24(7):392-393

6.Expression and significance of breast cancer suscepterbility gene 1 in leukemia

Chunxia MAO ; Fengru LIN ; Zhimin ZHANG

Journal of Leukemia & Lymphoma 2012;21(10):589-591

7.Evaluation of long-term efficacy of supplementary Lei's Danshen Tablet therapy in ischemic cardiomyopathy patients with heart failure

Xiaoying LUO ; Fengru ZHANG ; Wenhang QI

Chinese Traditional Patent Medicine 1992;0(11):-

8.Assessment of radial movement of left ventricle with velocity vector imaging in patients with dilated cardiomyopathy

Wei WANG ; Zhongwei SHI ; Houda HU ; Yan XU ; Fengru ZHANG

Chinese Journal of Ultrasonography 2010;19(6):480-484

9.Exploration and practiceof the hospital in the health reform

Fengru LI ; Peina SHI ; Jian ZHANG ; Jian LIU

Chinese Journal of Hospital Administration 2012;28(5):387-389

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 17 , 1/2 Show Home Prev Next End page: GO